U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06937814) titled 'The Effect of Humiome(R) Post LB on Gut COMFort in healthY Adult Volunteers' on April 14.
Brief Summary: The goal of this double-blind, randomized placebo-controlled study is to evaluate the effect of an 8-week supplementation of Humiome (R) Post LB (170 mg) on bowel movements in healthy adult volunteers compared to Placebo adjusted on baseline. The main question[s] it aims to answer [is/are]:
Does Humiome (R) Post LB improve bowel movements with self-reported GI issues?
Participants will be provided Humiome (R) Post LB (170 mg) for 8 weeks and asked to complete a study diary, questionnaires, and stool samples.
Study Start Date:...